These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19649890)

  • 1. Plasmepsins as antimalarial targets.
    Berry C
    Curr Opin Drug Discov Devel; 2000 Sep; 3(5):624-9. PubMed ID: 19649890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmepsins as potential targets for new antimalarial therapy.
    Ersmark K; Samuelsson B; Hallberg A
    Med Res Rev; 2006 Sep; 26(5):626-66. PubMed ID: 16838300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
    J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting functional residues in Plasmodium falciparum plasmepsins by combining sequence and structural analysis with molecular dynamics simulations.
    Valiente PA; Batista PR; Pupo A; Pons T; Valencia A; Pascutti PG
    Proteins; 2008 Nov; 73(2):440-57. PubMed ID: 18442137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes.
    Nöteberg D; Hamelink E; Hultén J; Wahlgren M; Vrang L; Samuelsson B; Hallberg A
    J Med Chem; 2003 Feb; 46(5):734-46. PubMed ID: 12593654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor.
    Gutiérrez-de-Terán H; Nervall M; Dunn BM; Clemente JC; Aqvist J
    FEBS Lett; 2006 Oct; 580(25):5910-6. PubMed ID: 17045991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an affinity matrix useful in the purification of natural inhibitors of plasmepsin II, an antimalarial-drug target.
    Ramírez AR; Guerra Y; Otero A; García B; Berry C; Mendiola J; Hernández-Zanui A; Chávez Mde L
    Biotechnol Appl Biochem; 2009 Feb; 52(Pt 2):149-57. PubMed ID: 18471091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum.
    Bonilla JA; Moura PA; Bonilla TD; Yowell CA; Fidock DA; Dame JB
    Int J Parasitol; 2007 Mar; 37(3-4):317-27. PubMed ID: 17207486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodomain processing of recombinant plasmepsin II and IV, the aspartic proteases of Plasmodium falciparum, is auto- and trans-catalytic.
    Kim YM; Lee MH; Piao TG; Lee JW; Kim JH; Lee S; Choi KM; Jiang JH; Kim TU; Park H
    J Biochem; 2006 Feb; 139(2):189-95. PubMed ID: 16452306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts.
    Meyers MJ; Goldberg DE
    Curr Top Med Chem; 2012; 12(5):445-55. PubMed ID: 22242846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity and inhibition of the food vacuole plasmepsin from the rodent malaria parasite Plasmodium chabaudi.
    Martins TM; Domingos A; Berry C; Wyatt DM
    Acta Trop; 2006 Feb; 97(2):212-8. PubMed ID: 16329985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmepsin inhibitors: design, synthesis, inhibitory studies and crystal structure analysis.
    Kesavulu MM; Prakasha Gowda AS; Ramya TN; Surolia N; Suguna K
    J Pept Res; 2005 Oct; 66(4):211-9. PubMed ID: 16138859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally-occurring and recombinant forms of the aspartic proteinases plasmepsins I and II from the human malaria parasite Plasmodium falciparum.
    Tyas L; Gluzman I; Moon RP; Rupp K; Westling J; Ridley RG; Kay J; Goldberg DE; Berry C
    FEBS Lett; 1999 Jul; 454(3):210-4. PubMed ID: 10431809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into the activation of P. vivax plasmepsin.
    Bernstein NK; Cherney MM; Yowell CA; Dame JB; James MN
    J Mol Biol; 2003 Jun; 329(3):505-24. PubMed ID: 12767832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New paradigm of an old target: an update on structural biology and current progress in drug design towards plasmepsin II.
    Dan N; Bhakat S
    Eur J Med Chem; 2015 May; 95():324-48. PubMed ID: 25827401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic alpha,alpha-difluoroketone hydrates.
    Fäh C; Hardegger LA; Baitsch L; Schweizer WB; Meyer S; Bur D; Diederich F
    Org Biomol Chem; 2009 Oct; 7(19):3947-57. PubMed ID: 19763297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial Phytochemicals Identification from
    Shah AP; Parmar GR; Sailor GU; Seth AK
    Folia Med (Plovdiv); 2019 Dec; 61(4):584-593. PubMed ID: 32337872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A target safety assessment of the potential toxicological risks of targeting plasmepsin IX/X for the treatment of malaria.
    Barber J; Sikakana P; Sadler C; Baud D; Valentin JP; Roberts R
    Toxicol Res (Camb); 2021 Mar; 10(2):203-213. PubMed ID: 33884171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy.
    Omara-Opyene AL; Moura PA; Sulsona CR; Bonilla JA; Yowell CA; Fujioka H; Fidock DA; Dame JB
    J Biol Chem; 2004 Dec; 279(52):54088-96. PubMed ID: 15491999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pepsinogen-like activation intermediate of plasmepsin II revealed by molecular dynamics analysis.
    Friedman R; Caflisch A
    Proteins; 2008 Dec; 73(4):814-27. PubMed ID: 18498105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.